Insomnia Market Report by Therapy Type, Drug Class, Distribution Channel, and Region 2024-2032

Description

List of Tables

The global insomnia market size reached US$ 5.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2032, exhibiting a growth rate (CAGR) of 2.69% during 2024-2032.

Insomnia is a sleep disorder that can lower energy levels and affect the mood, health, work performance, and overall life quality of an individual. Its common causes include stress, long travels, hectic work schedules, poor sleep habits, binge eating, and excessive consumption of nicotine, caffeine, and alcohol. It can also be associated with mental health disorders, such as post-traumatic stress, and the use of drugs like antidepressants for asthma or blood pressure and over-the-counter (OTC) for pain relief, allergy, and cold. Its treatment options, such as cognitive-behavioral therapy (CBT), OTC sleep aids, and prescription medications like Eszopiclone and Ramelteon, are currently available worldwide.

Insomnia Market Trends:

The coronavirus disease (COVID-19) pandemic generated unprecedented changes in lives, including social isolation and innumerable work challenges and family obligations. This acts as a major stressful event that impacted the sleep patterns of millions and strengthened the market growth. Moreover, medical conditions, such as chronic pain, cancer, diabetes, heart disease, asthma, gastroesophageal reflux disease (GERD), overactive thyroid, Parkinson's disease, and Alzheimer's disease, are usually linked with insomnia. Hence, the increasing number of individuals suffering from these ailments is driving the demand for insomnia medications. Apart from this, hormonal shifts during the menstrual cycle and menopause can lead to the risk of developing insomnia, which is contributing to the market growth. In addition, as changes in sleep patterns, activity, and health and the rising use of prescription drugs can increase the chance of insomnia among older people, the growing geriatric population globally is catalyzing the demand for insomnia medical treatment. Furthermore, increasing investments in testing new treatments, interventions, and tests to prevent, detect, treat, and manage insomnia are anticipated to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global insomnia market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapy type, drug class and distribution channel.

Breakup by Therapy Type:

Non-Pharmacological Therapy

Hypnotherapy

Cognitive Behavioral Therapy

Medical Devices

Others

Pharmacological Therapy

Prescription Sleep Aids

Over-The-Counter Sleep Aids

Breakup by Drug Class:

Antidepressants

Melatonin Antagonist

Benzodiazepines

Nonbenzodiazepines

Orexin Antagonist

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.

Key Questions Answered in This Report

1. What was the size of the global insomnia market in 2023?
2. What is the expected growth rate of the global insomnia market during 2024-2032?
3. What are the key factors driving the global insomnia market?
4. What has been the impact of COVID-19 on the global insomnia market?
5. What is the breakup of the global insomnia market based on the therapy type?
6. What is the breakup of the global insomnia market based on the drug class?
7. What are the key regions in the global insomnia market?
8. Who are the key players/companies in the global insomnia market?

Product Code: SR112024A6148

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Insomnia Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Therapy Type

6.1 Non-Pharmacological Therapy
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 Hypnotherapy
  - 6.1.2.2 Cognitive Behavioral Therapy
  - 6.1.2.3 Medical Devices
  - 6.1.2.4 Others
- 6.1.3 Market Forecast
6.2 Pharmacological Therapy
- 6.2.1 Market Trends
- 6.2.2 Key Segments
  - 6.2.2.1 Prescription Sleep Aids
  - 6.2.2.2 Over-The-Counter Sleep Aids
- 6.2.3 Market Forecast

7 Market Breakup by Drug Class

7.1 Antidepressants
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Melatonin Antagonist
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Benzodiazepines
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Nonbenzodiazepines
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Orexin Antagonist
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Drug Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Online Pharmacies
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Astellas Pharma Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Aurobindo Pharma Limited
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
- 14.3.3 Biocodex
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
- 14.3.4 Eisai Co. Ltd.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
  - 14.3.4.4 SWOT Analysis
- 14.3.5 Mallinckrodt Pharmaceuticals
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
- 14.3.6 Merck & Co. Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Neurim Pharmaceuticals Inc.
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Pfizer Inc.
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Sanofi S.A.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Takeda Pharmaceutical Company Limited
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Vanda Pharmaceuticals Inc.
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials

Product Code: SR112024A6148

List of Figures

Figure 1: Global: Insomnia Market: Major Drivers and Challenges
Figure 2: Global: Insomnia Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2023
Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2023
Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2023
Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Insomnia Industry: SWOT Analysis
Figure 82: Global: Insomnia Industry: Value Chain Analysis
Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Insomnia Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million US$), 2024-2032
Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Insomnia Market: Competitive Structure
Table 7: Global: Insomnia Market: Key Players

Insomnia Market Report by Therapy Type, Drug Class, Distribution Channel, and Region 2024-2032

Description

Table of Contents

List of Tables

Insomnia Market Trends:

Key Market Segmentation:

Breakup by Therapy Type:

Breakup by Drug Class:

Breakup by Distribution Channel:

Breakup by Region:

Competitive Landscape:

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Insomnia Market

6 Market Breakup by Therapy Type

7 Market Breakup by Drug Class

8 Market Breakup by Distribution Channel

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

List of Figures

List of Tables